The Clock Is Running: FDA’s Prior- Knowledge Draft Could Change What Gene Therapy Developers Have to Prove Twice
This article, published in The PDA WCC Insider, was authored by Senior Consultant Patrick Mains.
Forward Thinking: Read the latest in industry breakthroughs.
This article, published in The PDA WCC Insider, was authored by Senior Consultant Patrick Mains.
A recent article titled, “A Novel Approach To Managing Risks In Aseptic Processing Of Cell & Gene Therapies,” written by ValSource Senior Consultants Darius Pillsbury and Tiffany Baker was published in Cell & Gene, Outsourced Pharma, and Bioprocess Online.
This is the first in a series of three articles that will be published.
Read the latest in industry breakthroughs.
Available to help you achieve a high-performing workforce.
Our consultants are highly-recognized for their Annex 1 knowledge and expertise. We provide a plan forward through Annex 1 updates, today and into the future.